356 related articles for article (PubMed ID: 20225211)
1. Doxorubicin conjugated to D-alpha-tocopheryl polyethylene glycol succinate and folic acid as a prodrug for targeted chemotherapy.
Anbharasi V; Cao N; Feng SS
J Biomed Mater Res A; 2010 Sep; 94(3):730-43. PubMed ID: 20225211
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin conjugated to D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS): conjugation chemistry, characterization, in vitro and in vivo evaluation.
Cao N; Feng SS
Biomaterials; 2008 Oct; 29(28):3856-65. PubMed ID: 18606445
[TBL] [Abstract][Full Text] [Related]
3. Enhanced toxicity and cellular uptake of methotrexate-conjugated nanoparticles in folate receptor-positive cancer cells by decorating with folic acid-conjugated d-α-tocopheryl polyethylene glycol 1000 succinate.
Junyaprasert VB; Dhanahiranpruk S; Suksiriworapong J; Sripha K; Moongkarndi P
Colloids Surf B Biointerfaces; 2015 Dec; 136():383-93. PubMed ID: 26433645
[TBL] [Abstract][Full Text] [Related]
4. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
[TBL] [Abstract][Full Text] [Related]
5. Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery.
Zhang Z; Huey Lee S; Feng SS
Biomaterials; 2007 Apr; 28(10):1889-99. PubMed ID: 17197019
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide releasing d-α-tocopheryl polyethylene glycol succinate for enhancing antitumor activity of doxorubicin.
Song Q; Tan S; Zhuang X; Guo Y; Zhao Y; Wu T; Ye Q; Si L; Zhang Z
Mol Pharm; 2014 Nov; 11(11):4118-29. PubMed ID: 25222114
[TBL] [Abstract][Full Text] [Related]
7. The cancer targeting potential of D-α-tocopheryl polyethylene glycol 1000 succinate tethered multi walled carbon nanotubes.
Mehra NK; Verma AK; Mishra PR; Jain NK
Biomaterials; 2014 May; 35(15):4573-88. PubMed ID: 24612818
[TBL] [Abstract][Full Text] [Related]
8. A pH-sensitive prodrug strategy to co-deliver DOX and TOS in TPGS nanomicelles for tumor therapy.
Xiong S; Wang Z; Liu J; Deng X; Xiong R; Cao X; Xie Z; Lei X; Chen Y; Tang G
Colloids Surf B Biointerfaces; 2019 Jan; 173():346-355. PubMed ID: 30316081
[TBL] [Abstract][Full Text] [Related]
9. Formulation of Docetaxel by folic acid-conjugated d-α-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS(2k)) micelles for targeted and synergistic chemotherapy.
Mi Y; Liu Y; Feng SS
Biomaterials; 2011 Jun; 32(16):4058-66. PubMed ID: 21396707
[TBL] [Abstract][Full Text] [Related]
10. pH-sensitive nanoparticles of poly(L-histidine)-poly(lactide-co-glycolide)-tocopheryl polyethylene glycol succinate for anti-tumor drug delivery.
Li Z; Qiu L; Chen Q; Hao T; Qiao M; Zhao H; Zhang J; Hu H; Zhao X; Chen D; Mei L
Acta Biomater; 2015 Jan; 11():137-50. PubMed ID: 25242647
[TBL] [Abstract][Full Text] [Related]
11. Addition of TPGS to folate-conjugated polymer micelles for selective tumor targeting.
Zhao H; Yung LY
J Biomed Mater Res A; 2009 Nov; 91(2):505-18. PubMed ID: 18985763
[TBL] [Abstract][Full Text] [Related]
12. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells.
Bao Y; Guo Y; Zhuang X; Li D; Cheng B; Tan S; Zhang Z
Mol Pharm; 2014 Sep; 11(9):3196-209. PubMed ID: 25102234
[TBL] [Abstract][Full Text] [Related]
13. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles.
Yu P; Yu H; Guo C; Cui Z; Chen X; Yin Q; Zhang P; Yang X; Cui H; Li Y
Acta Biomater; 2015 Mar; 14():115-24. PubMed ID: 25498306
[TBL] [Abstract][Full Text] [Related]
14. A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery.
Bao Y; Yin M; Hu X; Zhuang X; Sun Y; Guo Y; Tan S; Zhang Z
J Control Release; 2016 Aug; 235():182-194. PubMed ID: 27264552
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy.
Zhang J; Tao W; Chen Y; Chang D; Wang T; Zhang X; Mei L; Zeng X; Huang L
J Mater Sci Mater Med; 2015 Apr; 26(4):165. PubMed ID: 25791459
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of pH-responsive folate-functionalized poloxamer 407-TPGS-mixed micelles on targeted delivery of anticancer drugs.
Butt AM; Mohd Amin MC; Katas H
Int J Nanomedicine; 2015; 10():1321-34. PubMed ID: 25709451
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin Encapsulated in TPGS-Modified 2D-Nanodisks Overcomes Multidrug Resistance.
Jiang T; Zhang C; Sun W; Cao X; Choi G; Choy JH; Shi X; Guo R
Chemistry; 2020 Feb; 26(11):2470-2477. PubMed ID: 31912555
[TBL] [Abstract][Full Text] [Related]
18. Induction of Mitochondrial Cell Death and Reversal of Anticancer Drug Resistance via Nanocarriers Composed of a Triphenylphosphonium Derivative of Tocopheryl Polyethylene Glycol Succinate.
Singh Y; Viswanadham KKDR; Pawar VK; Meher J; Jajoriya AK; Omer A; Jaiswal S; Dewangan J; Bora HK; Singh P; Rath SK; Lal J; Mishra DP; Chourasia MK
Mol Pharm; 2019 Sep; 16(9):3744-3759. PubMed ID: 31441308
[TBL] [Abstract][Full Text] [Related]
19. Co-delivery of Doxorubicin and D-α-Tocopherol Polyethylene Glycol 1000 Succinate by Magnetic Nanoparticles.
Metin E; Mutlu P; Gündüz U
Anticancer Agents Med Chem; 2018; 18(8):1138-1147. PubMed ID: 29532763
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles.
Pan J; Feng SS
Biomaterials; 2008 Jun; 29(17):2663-72. PubMed ID: 18396333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
